TY - JOUR
T1 - GBA variation and susceptibility to multiple system atrophy
AU - Wernick, Anna I.
AU - Walton, Ronald L.
AU - Koga, Shunsuke
AU - Soto-Beasley, Alexandra I.
AU - Heckman, Michael G.
AU - Gan-Or, Ziv
AU - Ren, Yingxue
AU - Rademakers, Rosa
AU - Uitti, Ryan J.
AU - Wszolek, Zbigniew K.
AU - Cheshire, William P.
AU - Dickson, Dennis W.
AU - Ross, Owen A.
N1 - Publisher Copyright:
© 2020 Elsevier Ltd
PY - 2020/8
Y1 - 2020/8
N2 - Introduction: Genetic variants in the glucocerebrosidase (GBA) gene have been previously associated with susceptibility to synucleinopathies. The risk is well-established in Lewy body disease but is not as confirmed for multiple system atrophy (MSA). We aim to evaluate associations between exonic variants in GBA and risk of neuropathologically-confirmed multiple system atrophy (MSA). Methods: Sanger gene sequencing of GBA was performed on 167 pathologically confirmed MSA patients collected at Mayo Clinic Florida Brain Bank, and data were extracted from whole-genome sequencing of 834 clinical controls. Common GBA variants were assessed for association with MSA. Rare GBA variants (and also all GBA variants) were collapsed together and evaluated for association with MSA risk using a gene-burden test. Results: A total of 17 exonic GBA variants were observed, including a novel p.Q112X variant that is likely pathogenic in a patient with mixed parkinsonism-cerebellar subtype MSA. The more common p.N409S and p.L483P variants that recessively cause Gaucher's disease (GD), and are associated with risk of Lewy body disease, were not observed. When collapsing across all GBA variants, the presence of any GBA variant was significantly more frequent in MSA patients than in controls (OR = 1.90, P = 0.031). However, this association was driven by p.T408M, which had a significantly higher frequency in MSA patients compared to controls (OR = 4.21, P = 0.002). There was no significant association with risk of MSA for the p.E365K variant (OR = 0.79, P = 0.72). Conclusions: Other than the specific GBA p.T408M variant, coding GBA variants are not associated with risk of MSA.
AB - Introduction: Genetic variants in the glucocerebrosidase (GBA) gene have been previously associated with susceptibility to synucleinopathies. The risk is well-established in Lewy body disease but is not as confirmed for multiple system atrophy (MSA). We aim to evaluate associations between exonic variants in GBA and risk of neuropathologically-confirmed multiple system atrophy (MSA). Methods: Sanger gene sequencing of GBA was performed on 167 pathologically confirmed MSA patients collected at Mayo Clinic Florida Brain Bank, and data were extracted from whole-genome sequencing of 834 clinical controls. Common GBA variants were assessed for association with MSA. Rare GBA variants (and also all GBA variants) were collapsed together and evaluated for association with MSA risk using a gene-burden test. Results: A total of 17 exonic GBA variants were observed, including a novel p.Q112X variant that is likely pathogenic in a patient with mixed parkinsonism-cerebellar subtype MSA. The more common p.N409S and p.L483P variants that recessively cause Gaucher's disease (GD), and are associated with risk of Lewy body disease, were not observed. When collapsing across all GBA variants, the presence of any GBA variant was significantly more frequent in MSA patients than in controls (OR = 1.90, P = 0.031). However, this association was driven by p.T408M, which had a significantly higher frequency in MSA patients compared to controls (OR = 4.21, P = 0.002). There was no significant association with risk of MSA for the p.E365K variant (OR = 0.79, P = 0.72). Conclusions: Other than the specific GBA p.T408M variant, coding GBA variants are not associated with risk of MSA.
KW - GBA
KW - Genetics
KW - Multiple system atrophy
UR - http://www.scopus.com/inward/record.url?scp=85087291691&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85087291691&partnerID=8YFLogxK
U2 - 10.1016/j.parkreldis.2020.06.007
DO - 10.1016/j.parkreldis.2020.06.007
M3 - Article
C2 - 32623306
AN - SCOPUS:85087291691
SN - 1353-8020
VL - 77
SP - 64
EP - 69
JO - Parkinsonism and Related Disorders
JF - Parkinsonism and Related Disorders
ER -